News — academic research

Innovative Research is pleased to announce a strategic partnership with Bioz, Inc., a leading AI software company based in the Silicon Valley. This collaboration is designed to enhance the ability of our customers to find reliable, peer-reviewed products within our extensive inventory of biological samples. As a prominent supplier of lab reagents, including plasma, serum, tissues, and proteins, Innovative Research offers an impressive portfolio of over 65,000 high-quality human and animal biologicals. These have been cited in a multitude of scientific publications, underscoring their reliability and efficacy. The partnership with Bioz will provide real-time product application data directly on our...

We have entered a new era in the world of obesity treatment, with a clear and distinct focus being on glucagon-like peptide-1 (GLP-1) drugs. These innovative therapies, which mimic the GLP-1 hormone found in the gut, have been making waves in the medical community and beyond. In fact, they were named as the 2023 Breakthrough of the Year by Science.org. From Diabetes to Obesity: The Journey of GLP-1 Drugs The story of GLP-1 drugs began in the early 1980s during research into diabetes and blood sugar regulation. Scientists discovered that GLP-1 could lower blood sugar levels in people, leading pharmaceutical...

As the year 2023 ends, we at Innovative Research want to thank you for your continued support and trust in our products and services. We are proud to be your partner in advancing scientific knowledge and innovation. To show our appreciation, we have prepared some amazing end-of-year promotions that you don’t want to miss. These promotions are designed to help you save time, money, and resources in your lab, while providing you with the highest quality biological samples and reagents for your research needs. Here are the 5 end-of-year promotions that you can take advantage of right now: Ready-to-Ship Repository:...

A series of sudden and unexplained deaths among seemingly healthy Amish children has been a mystery for years. New technology has allowed researchers to isolate the rare genetic mutation in the RYR2 gene that is to blame, offering answers and hope to the families impacted.

A genetic mutation in SERPINE1, the gene responsible for Plasminogen Activator Inhibitor-1 (PAI-1), seems to have ties back to leading a longer, healthier life. While complete PAI-1 deficiency can lead to a life-threatening clotting disorder, individuals who were heterozygous for this mutation seem to enjoy an extended lifespan on average.